These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Influence of whole-body vibration on biodistribution of the radiopharmaceutical [99mTc]methylene diphosphonate in Wistar rats. Pereira Mde O, Pinto Nde S, Monteiro Mde O, Santos-Filho SD, Carmo FS, Diniz CL, Marin PJ, Bernardo-Filho M. Int J Radiat Biol; 2013 Aug; 89(8):668-72. PubMed ID: 22849312 [Abstract] [Full Text] [Related]
24. [A new radiopharmaceutical for bone imaging: experimental study of 99mTc-HEDTMP]. Hu S, Deng H, Jiang S, Luo S, Lei Y. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):811-5. PubMed ID: 20842850 [Abstract] [Full Text] [Related]
28. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication. Wang TS, Fawwaz RA, Johnson LJ, Mojdehi GE, Johnson PM. J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832 [Abstract] [Full Text] [Related]
29. The impact of different bone tracers and acquisition times on image quality of equine bone scintigraphy. Mageed M, Dyab S, Swagemakers JH, Gerlach K. Vet Radiol Ultrasound; 2022 Sep; 63(5):593-600. PubMed ID: 35666549 [Abstract] [Full Text] [Related]
32. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate]. Otsuka N, Yoneda M, Sawai M, Saito J, Nagai K, Muranaka A, Terashima H, Yanagimoto S, Ito Y. Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135 [No Abstract] [Full Text] [Related]
37. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours. Ozcan Z, Burak Z, Erinç R, Dirlik A, Başdemir G, Sabah D, Ozkiliç H. Nucl Med Commun; 2001 Jun; 22(6):679-83. PubMed ID: 11403180 [Abstract] [Full Text] [Related]
38. Extraosseous accumulation of bone scanning agents in malignant brain tumors: comparison to semi-quantitative evaluation with 99mTc SPECT/201Tl SPECT and histological findings. Suzuki A, Togawa T, Kuyama J, Nakahara T, Iuchi T, Oga M, Osato K, Takenouchi T. Ann Nucl Med; 2003 Jul; 17(5):387-92. PubMed ID: 12971637 [Abstract] [Full Text] [Related]
40. Pharmacokinetic and imaging evaluation of (99m)Tc-HBIDP as a potential bone imaging agent. Qiu L, Lin J, Nan B, Lv G, Cheng W. Pak J Pharm Sci; 2015 May; 28(3):815-8. PubMed ID: 26004712 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]